ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666707 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666707; 2) Community: the network communities that were significantly associated with the response to NSC 666707; 3) Molecule: the relationships between components within communities and NSC 666707; 4) MDR: the compounds that were significantly associated with the NSC 666707.

NSC Compound Enrichment Correlation
NSC 33566 Null 0.0304779558345019 -0.33741581
NSC 335989 Acetamide, 2,2,2-trifluoro-N-(5,6,7,9-tetrahydro-2-hydroxy-1,3,10-trimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0304779558345019 0.048312861
NSC 628122 Null 0.0304779558345019 -0.162827
NSC 666871 Null 0.0304779558345021 0.11340049
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0304779558345021 0.14353093
NSC 709237 Camptothecin Derivative 0.0304779558345021 0.27015516
NSC 713019 Null 0.0304779558345021 0.25071489
NSC 721514 2-(N,N-bis(2-chloroethyl)phosphorodiamidoxy)methyl-1-methyl- 5-methoxyindole-4,7-dione 0.0304779558345021 0.17453323
NSC 724706 Null 0.0304779558345021 0.082189705
NSC 729831 2-{4-[(1E)-3-pyridine-4-yltriaz-1-enyl]phenyl}-1H-benzimidaz ole 0.0304779558345021 0.015187656
Total:73  Current:48    [First] [Prev] [Next] [Last]